人神经胶质细胞瘤细胞；U251(STR)FH0159
价格：￥1400
品牌名称：富衡型号：FH0159 原产地：中国大陆 更新时间：2026/10/21 7:56:21
产品摘要：U251 细胞是胶质母细胞瘤研究领域的经典细胞模型，因其高度模拟人类 GBM 的恶性特征 (快速增殖、强侵袭性、治疗抵抗) 而被广泛应用。
支付方式：
- 支付宝 微信 银行转账
产品完善度： 访问次数：685
企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
61成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：3年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：631275
详细内容
| 产品名称 | 人神经胶质细胞瘤细胞；U251 (STR) |
|---|---|
| 品牌 | FuHeng |
| 英文名 | U251 (STR) |
| 货号 | FH0159 |
| 规格 | 1×10⁶cells/T25培养瓶 |
| 价格 | 1400.0 |
| 培养 | DMEM(高糖)+10%FBS |
| 别称 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) |
| 形态特征 | 多角 |
| 生长特性 | 贴壁生长 |
| 培养条件 | 气相：空气，95%；CO2,5%温度：37℃ |
| 传代方法 | 1：2传代 |
| 组织来源 | 细胞瘤组织 |
| 细胞简介 | 人神经胶质细胞瘤细胞 U251（STR）来源于一位 56 岁男性的胶质母细胞瘤组织。 U251 细胞在神经科学和肿瘤学研究中应用广泛。它可用于研究神经胶质细胞瘤的发生、发展机制，探索肿瘤细胞的增殖、侵袭、迁移等特性，还可用于筛选针对神经胶质细胞瘤的潜在治疗药物，为相关疾病的治疗提供理论依据和实验基础。 |
| 培养基 | U251完全培养基 |
富衡相关文献
| 论文标题 | DOI | 发表时间 | 期刊 | 影响因子 | 作者列表 |
| Integrated tranｓcriptomic analysis reveals mitochondrial dysregulation and macrophage heterogeneity associated with MTHFD2 in glioblastoma | 10.1016/j.brainresbull.2026.111758 | 2026-01-31 | BRAIN RESEARCH BULLETIN | 3.7 | Binfeng Tu, Yulong Ji, Zilong Tan, Shiqi Cheng, Yan Zhang |
| H-ferritin engineered nanoplatｆorm reprograms ｍmbedbolism and immunity for glioblastoma immunotherapy | 10.1016/j.jconrel.2026.114613 | 2026-01-06 | JOURNAL OF CONTROLLED RELEASE | 11.5 | Jing Zuo, Yichun Huang, Hailong Tian, Siyuan Qin, Yonghao Yan, Han Yan, Yining Jiang, Lei Li, Shiqi Wang, Yongfeng Jia, Yuan Zhao, Canhua Huang |
| The study on potential pharmacological mechanism of semen strychny against glioma via network pharmacology analysis, molecular docking, and experimental verification | 10.1097/MD.0000000000046392 | 2025-12-19 | MEDICINE | 1.4 | Jiang Wenqu, Li Liang, Huang Qiwei, Zhu Guofeng, Zhang Zhixiong, Zhang Yi, Gao Xiang |
| Ketogenic diet inhibits glioma progression by promoting gut microbiota-derived butyrate production | 10.1016/j.ccell.2025.09.002 | 2025-09-25 | CANCER CELL | 44.5 | Ming-Liang Chen, Ying He, Xun-Hu Dong, Hao-Fei Liu, Ze-Xuan Yan, Xiao-Lu Lu, Qing-Qing Miao, Qing-Ning Zhao, Hang Zhang, Li Luo, Shuai Wang, Jing-Yuan Li, Dong-Fang Xiang, Yong Lin, Tian-Ran Li, Xin-Yue Zhou, Yang-Yang Zhou, Min Mao, Xia Zhang, Hong Wei, Yu Shi, Xin-Dong Liu, Yi-Fang Ping, Xiu-Wu Bian |
| Multi-pathway mechanisms of Liujunzi decoction in promoting glioma apoptosis and reversing drug resistance: network pharmacology and experimental validation | 10.3389/fphar.2025.1682550 | 2025-09-24 | Frontiers in Pharmacology | 4.8 | Jinxiang Huang, Shengnan Lin, Lei Lin, Luning Xu, Dezhi Kang |
| Multimerin-1 modulates macrophage M2 polarization and enhances tumor cell stemness in glioblastoma | 10.1080/01616412.2025.2520060 | 2025-06-21 | NEUROLOGICAL RESEARCH | 1.5 | Chao Huang, Xue-Bin Yu, Yong-Zhi Zhou, Xiao-Bing Zhang, Chang-Ming Dong, Wu-Qiao Bao |
| Betulinic Acid Inhibits Glioma Progression by Inducing Ferroptosis Through the PI3K/Akt and NRF2/HO-1 Pathways | 10.1002/jgm.70011 | 2025-02-18 | JOURNAL OF GENE MEDICINE | 2.2 | Jinxiang Huang, Qixuan Li, Hongxiang Wang, Shuai Zhang, Xiaorong Zhou, Fang Huang, Juxiang Chen, Luning Xu, Dezhi Kang |
| IDH1-mutant ｍmbedbolite D-2-hydroxyglutarate inhibits proliferation and sensitizes glioma to temozolomide via down-regulating ITGB4/PI3K/AKT | 10.1038/s41420-024-02088-y | 2024-07-09 | Cell Death Discovery | 6.1 | Tong Shuangmei, Wu Jian, Song Yun, Fu Wenhuan, Yuan Yifan, Zhong Pin, Liu Yinlong, Wang Bin |
| YTHDF1 promotes the viability and self‑renewal of glioma stem cells by enhancing LINC00900 stability | 10.3892/ijo.2024.5641 | 2024-03-28 | INTERNATIONAL JOURNAL OF ONCOLOGY | 4.5 | Yuanhai Zhang, Yi Zhu, Yating Zhang, Zixiang Liu, Xudong Zhao |
| HNF1A induces glioblastoma by upregulating EPS8 and activating PI3K/AKT signaling pathway | 10.1016/j.bcp.2024.116133 | 2024-03-15 | BIOCHEMICAL PHARMACOLOGY | 5.3 | Gang Yang, Fei Su, Bin-xiao Han, Hong-xin Su, Chen-hao Guo, Shao-hua Yu, Quan-lin Guan, Xiao-ming Hou |
| SENP1-mediated SUMOylation of SIRT1 affects glioma development through the NF-κB pathway | 10.1016/j.yexcr.2023.113822 | 2023-10-21 | EXPERIMENTAL CELL RESEARCH | 3.7 | Xin Liu, Shenglin Zhang, Yi Dong, Yunpeng Xie, Qingshan Li |
| Knockdown of T Cell Immunoglobulin and Mucin 1 (Tim-1) Suppresses Glioma Progression Through Inhibition of the Cytokine-PI3K/AKT Pathway | 10.2147/OTT.S255117 | 2023-04-07 | OncoTargets and Therapy | 4.0 | Peng Zhou, Maoxing Fei, Yanling Han, Mengliang Zhou, Handong Wang |
| TRAF3IP3 promotes glioma progression through the ERK signaling pathway | 10.3389/fonc.2022.776834 | 2022-09-16 | Frontiers in Oncology | 5.738 | Lin Qi, Chen Zhen, Shen Zhao-Li, Xue Fei, Qin Jia-Jun, Kang Xi-Peng, Chen Zhong-Rong, Xia Zhong -Yuan, Gao Liang, Chen Xian-Zhen |
| Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy in vitro and in vivo | 10.1186/s40779-022-00369-0 | 2022-02-14 | Military Medical Research | 34.915 | He Ying, Dong Xun-Hu, Zhu Qiong, Xu Ya-Li, Chen Ming-Liang, Liu Zheng |
| Inhibition of Cathepsin S Restores TGF-β-induced Epithelial-to-mesenchymal Transition and Tight Junction Turnover in Glioblastoma Cells | 10.7150/jca.50631 | 2021-01-15 | Journal of Cancer | 4.207 | Li Wei, Naiyuan Shao, Ya Peng, Peng Zhou |
| In vivo pharmacodynamic evaluation of antidepressants based on flux mitochondrial Cys in living mice via near infrared fluorescence imaging | 10.1039/D0AN01364A | 2020-08-01 | ANALYST | 3.978 | Xin Wang, Jiali Zha, Wei Zhang, Wen Zhang, Bo Tang |
上海衡生物科技有限公司
上海富衡生物科技有限公司（以下简称“富衡”）是主要从事生物科技，医药科技领域内的技术开发，技术咨询，技术服务的高新技术企业。是一家专注于细胞相关技术，服务及产品的高科技生命科学和生物技术领域企业。
富衡提供专业的细胞鉴定服务（采用ATCC细胞鉴定准－－STR基因分型技术），并建立完善鉴定，种类齐全的细胞资源库，能为广大科研工作者在发表高质量文章时提供可靠的“细胞鉴定依据”。公司拥有一个蓬勃朝气的年轻团队，不断进取，我们密切注视细胞技术领域的发展，并且于员工的技术和素质培训。团队中博士硕士以上学历人士达80％，有很强的技术支持及研发能力。
专注于细胞培养 PARTNERS 合作伙伴
热门标签：人神经胶质细胞瘤细胞,U251,U251细胞
